Anti-cytokine autoantibodies are associated with opportunistic infection in patients with thymic neoplasia

Burbelo, Peter D.; Browne, Sarah K.; Sampaio, Elizabeth P.; Giaccone, Giuseppe; Zaman, Rifat; Kristosturyan, Ervand; Rajan, Arun; Ding, Li; Ching, Kathryn H.; Berman, Arlene; Oliveira, Joao B.; Hsu, Amy P.; Klimavicz, Caitlin M.; Iadarola, Michael J.; Holland, Steven M..
Artículo en Inglés | ARCA | ID: arc-22919

Documentos relacionados

  1. Identification of distinct cytokine/chemokine profiles in dermatomyositis with anti-transcriptional intermediary factor 1-γ antibody.
  2. Research progress on the dermatomyositis specific autoantibodies and malignancy associated dermatomyositis.
  3. PNMA2 forms immunogenic non-enveloped virus-like capsids associated with paraneoplastic neurological syndrome.
  4. Coexisting autoantibodies against transcription factor Sp4 are associated with decreased cancer risk in patients with dermatomyositis with anti-TIF1γ autoantibodies.
  5. Anti-cytokine autoantibodies and inborn errors of immunity.
  6. Long-term risks of malignancy in myositis-specific antibody-positive idiopathic inflammatory myopathy.
  7. Disseminated nocardiosis and anti-GM-CSF antibodies.
  8. Antibodies as biomarkers for cancer risk: a systematic review.
  9. Immune checkpoint inhibitor-associated central nervous system autoimmunity.
  10. Optimizing cancer immunotherapy: Is it time for personalized predictive biomarkers?